24 HR Memantine hydrochloride 14 MG Extended Release Oral Capsule
1 INDICATIONS AND USAGE Memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride extended-release capsules are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )
Mylan Pharmaceuticals Inc.
CAPSULE ORANGE MYLAN MT 14
Related Pills
24 HR Memantine hydrochloride 28 MG Extended Release Oral Capsule
Mylan Pharmaceuticals Inc.
24 HR Memantine hydrochloride 21 MG Extended Release Oral Capsule
Mylan Pharmaceuticals Inc.
24 HR Memantine hydrochloride 7 MG Extended Release Oral Capsule
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Memantine Hydrochloride Extended-Release capsules are available containing 7 mg, 14 mg, 21 mg or 28 mg of memantine hydrochloride, USP. The 7 mg capsules are hard shell gelatin capsules with a light peach opaque cap and light peach opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over MT 7 in black ink on the cap and body. They are available as follows: NDC 0378-5435-93 bottles of 30 capsules The 14 mg capsules are hard shell gelatin capsules with a light peach opaque cap and light green opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over MT 14 in black ink on the cap and body. They are available as follows: NDC 0378-5436-93 bottles of 30 capsules NDC 0378-5436-77 bottles of 90 capsules The 21 mg capsules are hard shell gelatin capsules with a white opaque cap and light green opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over MT 21 in black ink on the cap and body. They are available as follows: NDC 0378-5437-93 bottles of 30 capsules The 28 mg capsules are hard shell gelatin capsules with a light green opaque cap and light green opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over MT 28 in black ink on the cap and body. They are available as follows: NDC 0378-5438-93 bottles of 30 capsules NDC 0378-5438-77 bottles of 90 capsules Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container using a child-resistant closure.
More pills like CAPSULE MYLAN MT 14